Clinical Trial Update: Pantoprazole in Cisplatin Nephrotoxicity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pantoprazole for cisplatin-induced nephrotoxicity in oncology patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cisplatin-induced Nephrotoxicity
• Oncology

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Oncology | Phase 3 | Status: RECRUITING